Abstract:Gastrodin (GAS) is the main chemical component of the traditional Chinese herb Gastrodia elata (called "Tianma" in Chinese), which has been used to treat neurological conditions, including headaches, epilepsy, stroke, and memory loss. To our knowledge, it is unclear whether GAS has a therapeutic effect on Huntington's disease (HD). In the present study, we evaluated the effect of GAS on the degradation of mutant huntingtin protein (mHtt) by using PC12 cells transfected with N-terminal mHtt Q74. We found that 0.1–100 μM GAS had no effect on the survival rate of Q23 and Q74 PC12 cells after 24–48 h of incubation. The ubiquitin–proteasome system (UPS) is the main system that clears misfolded proteins in eukaryotic cells. Mutated Htt significantly upregulated total ubiquitinated protein (Ub) expression, decreased chymotrypsin-like, trypsin-like and caspase-like peptidase activity, and reduced the colocalization of the 20S proteasome with mHtt. GAS (25 μM) attenuated all of the abovementioned pathological changes, and the regulatory effect of GAS on mHtt was found to be abolished by MG132, a proteasome inhibitor. The autophagy–lysosome pathway (ALP) is another system for misfolded protein degradation. Although GAS downregulated the expression of autophagy markers (LC3II and P62), it increased the colocalization of LC3II with lysosomal associated membrane protein 1 (LAMP1), which indicates that ALP was activated. Moreover, GAS prevented mHtt-induced neuronal damage in PC12 cells. GAS has a selective effect on mHtt in Q74 PC12 cells and has no effect on Q23 and proteins encoded by other genes containing long CAGs, such as Rbm33 (10 CAG repeats) and Hcn1 (>30 CAG repeats). Furthermore, oral administration of 100 mg/kg GAS increased grip strength and attenuated mHtt aggregates in B6-hHTT130-N transgenic mice. This is a high dose (100 mg/kg GAS) when compared with experiments on HD mice with other small molecules. We will design more doses to evaluate the dose–response relationship of the inhibition effect of GAS on mHtt in our next study. In summary, GAS can promote the degradation of mHtt by activating the UPS and ALP, making it a potential therapeutic agent for HD.

Gastrodin Improves the Activity of the Ubiquitin–Proteasome System and the Autophagy–Lysosome Pathway to Degrade Mutant Huntingtin

Discovery of an Autophagy Inducer J3 to Lower Mutant Huntingtin and Alleviate Huntington’s Disease-Related Phenotype

Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex

Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions Via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington’s Disease

Gastrodin Alleviates Cerebral Ischemic Damage in Mice by Improving Anti-oxidant and Anti-inflammation Activities and Inhibiting Apoptosis Pathway

CGS21680 Attenuates Symptoms of Huntington's Disease in a Transgenic Mouse Model

Gastrodin - A potential drug used for the treatment of Tourette Syndrome

mTOR inhibition in Q175 Huntington's disease model mice facilitates neuronal autophagy and mutant huntingtin clearance

Protective Effects of Gastrodin Against Autophagy‐Mediated Astrocyte Death

Gastrodin Attenuates Tourette Syndrome by Regulating EAATs and NMDA Receptors in the Striatum of Rats.

Effect of gastrodin against cognitive impairment and neurodegeneration in APP/PS1 mice via regulating gut microbiota–gut–brain axis

Gastrodin Ameliorates Depressive-Like Behaviors and Up-Regulates the Expression of BDNF in the Hippocampus and Hippocampal-Derived Astrocyte of Rats

GLUT4 mediates the protective function of gastrodin against pressure overload-induced cardiac hypertrophy

Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease

Gastrodin Attenuates Bilateral Common Carotid Artery Occlusion-Induced Cognitive Deficits Via Regulating Aβ-Related Proteins and Reducing Autophagy and Apoptosis in Rats

Gastrodin Protects H9c2 Cardiomyocytes Against Oxidative Injury by Ameliorating Imbalanced Mitochondrial Dynamics and Mitochondrial Dysfunction

Lycium Barbarum Polysaccharide Attenuates the Cytotoxicity of Mutant Huntingtin and Increases the Activity of AKT

A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro.

Gastrodin relieves cognitive impairment by regulating autophagy via PI3K/AKT signaling pathway in vascular dementia

Lowering mutant huntingtin by small molecules relieves Huntington’s disease symptoms and progression

Gastrodin improves nerve cell injury and behaviors of depressed mice through Caspase-3-mediated apoptosis